Dxlab
Somerville, US · Founded 2020 · Delaware corporation · 1 known investors
DxLab develops multiplex molecular diagnostic technology (LAMP+) for rapid, low-cost point-of-care infectious disease testing, including its DxHub portable testing platform, DxTests, and ready-to-use LAMP master mixes. Founded by MIT and Harvard graduates, it serves public health applications such as Mpox and antimicrobial resistance detection.
Founders & leadership
Dxlab was founded in 2020 by Louis Kang.
LK
Louis KangCo-founder & Business Development Lead
FF
Fahim FarzadfardNamed on SEC filing
AM
Adam MullinaxNamed on SEC filing
JS
Jeong Seuk KangNamed on SEC filing
HS
Ho-Jun SukinCo-founder & CEO
Board
CC

Investors · 1
Reported raises · per SEC filings
Form D private placements$4M disclosed across 1 round · 2020
▶$4MraisedDec 2020 · 6 investors · Other Health CareRule 506(b)
▶$4MraisedDec 2020 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Fahim FarzadfardDirector
- Adam MullinaxDirector
- Calvin ChinDirector
- Jeong Seuk KangDirector
- Ho-Jun SukExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapLabcorp24 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Cdxdiagnostics17 shared keywordsCDx Diagnostics offers a diagnostic platform that combines enhanced tissue sampling, AI-assisted analysis, 3D imaging, and genetic testing to detect precancerous cells and dysplasia. The technology is aimed at physicians for early detection and prevention of cancer, including esophageal cancer.
Quest Diagnostics14 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Companies competing with Dxlab for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Dxlab do?
- DxLab develops multiplex molecular diagnostic technology (LAMP+) for rapid, low-cost point-of-care infectious disease testing, including its DxHub portable testing platform, DxTests, and ready-to-use LAMP master mixes. Founded by MIT and Harvard graduates, it serves public health applications such as Mpox and antimicrobial resistance detection.
- Who founded Dxlab?
- Dxlab was founded by Louis Kang in 2020.
- Who are Dxlab's investors?
- Dxlab's investors include The E14 Fund.
- How much funding has Dxlab raised?
- Dxlab has disclosed $4M raised across 1 round.
- Where is Dxlab headquartered?
- Dxlab is headquartered in Somerville, US.
